According to the National Medicines Regulatory Authority Act No. 05 of 2015 the National Medicines Regulatory Authority shall be responsible for the regulation and control of registration, licensing, manufacture, importation and all other aspects pertaining to medical devices in a manner compatible with the National Medicines Policy;
As defined in the Act a “medical device” means any instrument, apparatus, appliance, software, material or any other article, whether used single or in combination, including the software necessary for its proper application intended by the manufacturer used in or on human beings for the purpose of:
and which does not achieve its intended action in or on the human body by pharmacological, immunological or metabolic means but which may be assisted in its function by such means;
A medical device does not include an Ayurveda device or a Homeopathy device;
The National Medicines Regulatory Authority (NMRA) is responsible to build a healthier nation by ensuring that medical devices available for supply in Sri Lanka are of acceptable quality, safety and fit for their intended purpose. As such all Medical devices which are categorized as in above definition and should be registered with the Authority and license to be obtained for manufacturing, importation, re-packaging, sale, distribution and offered for sale in Sri Lanka.All foreign medical device manufactures should submit application for registration through a Marketing Authorization Holder (local agent) in Sri Lanka who shall be responsible for the registration, licensing, importation, sale and distribution, handing of quality failures and all aspects pertaining to the particular medical device in Sri Lanka.
The Medical Device Evaluation Committee (MDEC) formed under NMRA Act carries out technical evaluation of the medical devices forwarded for registration by considering the quality, safety, effectiveness, need and cost of such devices. The MDEC consist of experts drawn from various specialties in medical and pharmaceutical fields who meets monthly to decide on applications submitted for marketing authorization of medicines and to make policy decisions relevant to marketing authorization of medicines.
All dossiers and related applications for medical device registration shall be accepted in accordance with the following procedure.
Prior to physical submission, applicants must complete the online application form via the following link:
https://docs.google.com/forms/d/e/1FAIpQLSf8-B5VcCc1VXW7WL0fUhRiiap2BH6fQ6DvN2a2Yj1JpzLXig/viewform?usp=sf_link
Alternatively,applicants may scan the designated QR code to access the same form published in NMRA web site.
All applications for medical device registration must:
Incomplete submissions will not be accepted for evaluation.
The applicant (Marketing Authorization Holder) shall:


There are two main types of consolidated dossiers for productregistration:
· FMSA + ProductRegistration Dossier for General Medical Devices and IVDDs.
· Product RegistrationDossier without FMSA for General Medical Devices, IVDDs & Listed devices (Forboth foreign & local manufacturers)
***Listed Medical Devices are exempted from manufacturingsite registration for foreign manufacturers***
· The applicant shall submit thecomplete consolidated dossier to the NMRA accepting point and the acceptingofficer shall verify the availability and completeness of documents inaccordance with the submission checklist prior to issuing the payment note.
· The accepting officer shallprocess the relevant payment based on; the type of application (SiteRegistration or Product Registration) and the information provided by the localagent in the Google form for medical device accepting.
· The applicant shall submit the bank slip to theAccounts Division of NMRA and shall obtain the original payment receipt and ayellow receipt from the Accounts Division.
· The applicant shall submit the consolidated dossieraccompanied by the yellow payment receipt, to the accepting point.
· The accepting officer shall verify the yellowreceipt issued by the accounts division and assign a dossier reference numberto the submitted dossier.
· Depending on the type of application, one of the following dossier number formats shall be used

· Upon submission, the acceptingofficer shall issue an acknowledgment to the applicant, including the assigne dossier reference number.
· Upon approval of the FMSA, the MDRD shall email the applicant a scannedcopy of the FMSA approval & if applicable attaching the approvedform (schedule IV form C and evaluation sheet) for processing SampleImport License (SIL)**. Theemail will also include the payment note for the Product RegistrationDossier (PRD).
· In the case of rejection or awaiting data for FMSA, an evaluation sheet will be shared with theapplicant without a payment note.
· The applicant shall make thepayment for PRD and submit the bankslip to the AccountsDivision of NMRA. After receiving the original payment receipt and a yellow receipt from theAccounts Division, the yellow receipt shall be submitted to the acceptingpoint.
· The accepting officer shall issuean acknowledgment confirming receipt of the PRD payment note.
**Applicable payments for issuance of the SILs will be handled by the NMRA Licensing division.
· The MDRD shall email the scanned copy of the approved form (schedule IV form C and evaluation sheet) for processing Sample Import License (SIL) to the applicant, if applicable.
· The applicant shall submit a scanned copy of the approved form (schedule IV form C and evaluation sheet) to the Licensing Division of the NMRA, proceed with the SIL payment, and submit the relevant payment slip to the Licensing Division for issuing the SIL.
· The applicant must submit a copy of the SIL & a request letter to initiate the evaluation process to the accepting point & the accepting officer shall issue an acknowledgment confirming receipt of the SIL copy.
· For General Medical Devices, registration from the following countries will be considered under the reliance pathway:
USA, UK, Australia, Canada, Japan, Norway, Switzerland& All European Union (EU) member countries
· For In Vitro Diagnostic(IVD) Medical Devices:
USA, UK, Australia, Canada, Japan, Norway, Switzerland, Singapore & All European Union (EU) member countries
If deficient data or samples are requested:
· The applicant must submit the required information and relevant payment within two (2) months from the date of notification email.
· Submissions shall be made tothe accepting point.
· Approved PRD applications shall be forwarded to the Licensing Division for issuing and the Registration Certificate and Import License to the applicant.
· Documents should be in a box file and a green tape should be pasted on the side of the box file.
· In the front page of the box file must include the Generic Name, Brand Name, Manufacturer name & address, local agent, type of dossier (refer to the ‘dossier number formats’ in the guideline) &separate space should be allocated for the dossier number.
· All the pages of the documents should be numbered from bottom to top.
· Index should be pasted on the inner side of the file indicating headings and correct page numbers.
· Details of the responsible person for the regulatory affairs including the name, company details, designation, email ID, contact number should be available in the dossier.
· Consolidated dossiers should be clearly separated as follows;
Type dossiers -‘FMSA + PRD’ for General Medical Devices & IVDDs
General Documents - common administrative documents & common technical documents
Section 1 - documents required for FMSA application
Section 2 - documents required for PRD
Type dossiers -‘PRD without FMSA ’ for General Medical Devices & IVDDs for foreign & local manufacturers
General Documents – common administrative documents & common technical documents
Section 1 – documents required for PRD
Following documents are mandatory;
· Letter of Authorization (LOA) from the legal manufacturer
If the legal manufacturer appointed more than one local agent, tabulated LOA including the details of all local agents, product range and manufacturing site should be submitted.
· Declaration letter confirming the type of dossier from the local agent
· Declaration letter confirming the submission of samples upon request of the authority
· Agency transfer letter issued by NMRA (If applicable)
· Valid Free Sale Certificate(FSC)
For verification and confirmation purposes, original FSC or any other verification method (QR code, web link etc.) should be provided at the time of writing the processing fee.
· Copy of GMP report issued by the NMRA for local manufacturers (If applicable)
· Copy of FMSA approval issued by NMRA or NMRA product registration certificate as evidence.
· ISO quality management system certificate
For Listed device - (ISO 13485:2016/2021 or ISO9001:2015)
Medical devices (except Listed Device) - ISO13485:2016/2021)
· Foreign country registration evidence documents (Product registration certificate or FSC issued by the relevant health authority)
Following documents should be submitted for FMSA application.
● Application form for FMSA
● Copy of Business Registration of the authorized local agent
● Copy of Board of Directors’ Registration of the authorized local agent (if applicable)
● Company Registration (Form 01/15/40)
● Declaration letters
o Declaration from manufacturer for local representation, manufacturing site status, readiness for inspection and accuracy of submitted documents
o Declaration letter from local regulatory Pharmacist/qualified person stating that information given in this application is correct
o Declaration letter from legal manufacturer mentioning the details of other manufacturing sites belong to the legal manufacturer which are not included in the application
o Consent Letter from local agent to withdraw the application when the NMRA noticed duplications
● Site Master File (SMF) - Site Master File should be submitted along with all the applications for FMSA of Medical Devices.
Note: It is required to submit information as per the NMRA requirements for Site Master File (Refer NMRA website)
● List of exporting countries
· Application form for Sample Import License (Form C)
· Application Form (Form A)
· Application Form (Form B)
· Device Details from the manufacturer
· Manufacturer declaration of conformity/ EC full quality assurance system certificate/ EU quality management system certificate or manufacturer EC declaration of conformity
· If CE marked medical devices: EC design examination certificate (If applicable)
· Summary Technical Documentation (STED) – refer GHTF guidelines
· Essential Requirement Check list – refer GHTF guidelines
· Risk Analysis Report (Eg: ISO 14971 standard)
· Certificate of Analysis (COA)/ finished product test report/ final product inspection test report
· Stability protocol with data report (if applicable)
· For Sterile medical devices;
o Sterility report
o Sterilization validation protocol with report
o EO residual test data for EO sterilized products
o Package Integrity data report
· Biological evaluation report (if applicable)
· Clinical evaluation test report (if applicable)
· For active medical devices; Electrical safety data and Electromagnetic Compatibility data report (Eg: IEC standard)
· For medical devices with measuring function; certification on medical devices, metrology or equivalent
· For radiation emitting medical devices; Atomic Energy Authority Approval certificate
· Third party test report (If applicable)
· Software Verification and Validation Report (If applicable)
· For devices containing biological material; a list of all materials used in the medical device and its manufacturing process that come from animal, human, microbial, or genetically modified (recombinant) sources.
· Bovine Spongiform Encephalopathy (BSE) report(If applicable)
· Product labels (Original/ artwork/ draft)
· Product catalogue or brochure
· For IVDD; Performance evaluation test report(Eg: Analytical , clinical)
· Instructions For Use (IFU) (If applicable)
· Patient Information Leaflet in Sinhala, Tamil& English languages for the point of care medical devices
· List of standard accessories, reagents and consumables (If applicable)
Please refer to Section 8.4: ‘Documents Required for PRD Application’ for the list of documents applicable to the above-mentioned type of dossier.
• Provisional Registration:
o Issued for first-time registration
o Valid for one (01) year or two (02) years, as specified in the certificate
• Full Registration:
o Issued upon satisfactory evaluation
o Valid for five (05) years, as specified in the certificate
• If additional information is requested by NMRA:
o The applicant must submit the required data within two (02) months
Failure to comply may result in delays or rejection of the application.
• Application for renewal should be made before six months from the date of expiry of registration. If additional information is requested by NMRA:
o The applicant must submit the required data within two (02) months.
Any change in product name, product specifications, packaging, indications, contents of product label, package insert, or product literature, or any relevant particulars of the registered product should not be made without the prior approval of the authority.
The registration of the product maybe cancelled if changes are made without the prior approval of the authority.
Any change of product which affects quality, safety & efficacy of the product should require a new application for registration.
This section explains the process for approval of manufacturers who would be eligible to apply for registration of their products in Sri Lanka.
Information is also given to provide guidance on the type of applications and how to apply for the approval of relevant manufacturing facilities.
Introduction & Scope:
The process applies for overseas manufacturing sites who intended to get marketing authorization for their products in Sri Lanka. The procedure includes a desk review of essential documents including the site master file. A GMP inspection of the site may be necessary before approval of the site.
A foreign manufacturer who wants to register products in Sri Lanka needs to appoint a Sri Lankan business entity as its local authorized agent. The local agent will furnish applications on behalf of its principal company, the foreign manufacturer. A separate application needs to be submitted to each manufacturing site from which the manufacturer plans to export products to Sri Lanka.
Application has to be submitted online via NMRA’s web portal eNMRA which requires uploading of essential information and documents to enable a desk review. If all documents indicate fulfilment of NMRA requirements, the next step would be to carry out a GMP inspection of the facility. The NMRA Act, No. 5 of 2015 (section 51) & regulations 2 to 10 of part I of medicines regulations pronounce the legal requirements. The NMRA would exempt onsite GMP inspection if the particular site had been inspected by a stringent NRA or WHO, in terms of regulation 24 of the medicines regulations. After these procedures, an approved foreign manufacturer can submit an application for marketing authorization of its products through the local agent.
Flow Chart- Foreign Manufacturing Site Approval
The process applies for local manufacturing sites who intended to get marketing authorization for their products in Sri Lanka. The procedure includes a desk review of essential documents including the site master file and several GMP Inspections.
A local manufacturer who wants to register products in Sri Lanka needs to furnish applications regarding his manufacturing facilities. A separate application needs to be submitted to each manufacturing site.
Application has to be submitted online via NMRA’s web portal eNMRA which requires uploading of essential information and documents to enable a desk review and GMP Inspections.
The NMRA Act, No. 5 of 2015 (section 51) & regulations 26 to 30 of part II of medicines regulations pronounce the legal requirements.
After these procedures, an approved Local manufacturer can submit application for formulation approvals.
After obtaining the formulation approval and GMP approval for commercial manufacturing of the facility, local manufacturer can apply for the product registration. After that, local manufacturer can apply for the manufacturing license.
Stages for beginners;
Site Master Files are submissions to NMRA used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of Medicines, Medical Devices, Borderline products and cosmetics.
References:
Good manufacturing practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization.
The National Medicines Regulatory Authority Act No. 5 of 2015 interprets GMP guidelines as ‘good manufacturing guidelines issued by the World Health Organization’. As such, the National Medicines Regulatory Authority (NMRA) adopts the WHO GMP guidelines along with its subsequent updates for the purpose of regulation of pharmaceutical manufacture. The manufacturers are expected to adhere to the Good Manufacturing Practices throughout their activities.
Pharmaceutical manufacturers who intend to apply for marketing authorization in Sri Lanka may be subjected to one or several GMP inspections prior to their site approvals.
GMP Guidelines available on WHO website:
WHO good manufacturing practices for pharmaceutical products: main principles:
https://www.who.int/medicines/areas/quality_safety/quality_assurance/TRS986annex2.pdf?ua=1
WHO good manufacturing practices for sterile pharmaceutical products:
WHO good manufacturing practices for biological products:
https://www.who.int/publications/m/item/annex-2-WHO-gmp-for-biological-products
Guideline on Approval of an Overseas Manufacturing Plant of Medicines
Guideline on Preparation of Site Master Files
Guideline for preparation and conduct of the GMP inspection
Those who are willing to apply for Waiver of registration for Medical Device please be kind enough to submit your properly filled application form and relevant documents to office of Sate Ministry of Production, Supply and Regulations & Pharmaceuticals.

Download WOR Application from here : WOR Application
Documents Required for Waiver of Registration.
Mandatory Documents
Where Applicable
Note: Incomplete application will not be tabled to WOR Committee.
Healthcare professional such as doctors, dentists, pharmacists and nurses are encouraged to report suspected adverse events encountered in their day to day practice. Using the ADR google form given by the following link here, you can report Adverse Events.
Report Adverse Events
Address :
Director General / CEO
National Medicines Regulatory Authority,
No: 120, Norris Canal Road,
Colombo 10.
Telephone :
+94 112 698 896, +94 112 698 897
Fax :
+94 112 689 704
A copy of the form shall be forwarded to Adverse Drug Reaction Monitoring Unit of the Department of Pharmacology, Faculty of Medicine, University of Colombo, Kynsey Road, Colombo 08. (TP/ Fax: +94 112 697 483).
The Advertising Evaluation Sub Committee of the NMRA regulates advertisements - printed and electronic material - related to medicines, devices, borderline products to ensure such advertisements are ethical, accurate and appropriate.
Advertisement includes any representation by any means whatsoever, for the purpose of promoting directly or indirectly the manufacture, sale or disposal of any medicine medical device, borderline product.
All the applicants who which to obtain approval for the advertisement on medicines, medical device and borderline products should be followed below procedure.
1. Submit the duly filled application (Please mention email address correctly for sending evaluation sheet) along with copy of valid registration certificate, story board of the advertisement to the accepting counter on every Friday (From 9.00 am to 3.30 pm)for obtaining the payment note for processing fee (1000USD).
2. Payment Receipt issued by account division should be submitted NMRA after the payment along with the application with following documents to accepting pharmacist (Every Friday from 9.00 am to 3.30 pm). Application should be submitted in a file. Accepting pharmacist accepts the application and assign a reference number.
a. Duly filled and signed application
b. Copy of the valid registration certificates
c. 3 sets of printed copies/story board of the advertisement (If advertisement is containing any sound/ video, story board and 2 CD s including the video clip or sound clip need to be submitted)
d. Supportive documents (Clinical data, test report etc.) for proving any claims
3. All the applications will be tabled to the committee (Once a month) and evaluation reports will be emailed to the applicants.
4. Approved letters can be collected from the issuing counter.in the advertisements
Applicants should consider the following when designing an advertisement:
Medical Devices Pricing

MDEC Sub Committee- (17th of June 2026)
105th MDEC Committee- (3rd of June 2026)
MDEC Sub Committee- (25th of May 2026)
104th MDEC Committee- (6th of May 2026)
103rd MDEC Committee- (8th of April 2026)
MDEC Sub Committee- (19th of March 2026)
102nd MDEC Committee- (4th of March 2026)
101st MDEC Committee- (11th of February 2026)
MDEC Sub Committee- (21st of January 2026)
100th MDEC Committee- 07th of January 2026
99th MDEC Committee- (10th of December 2025)
MDEC Sub Committee- (21st of November 2025)
98th MDEC Committee- (06th of November 2025)
MDEC Sub Committee- (17th of October 2025)
97th MDEC Committee (01st of October 2025)
MDEC Sub Committee- (22nd of September 2025)
96th MDEC Committee (03rd of September 2025)
MDEC Sub Committee- (21st of August 2025)
95th MDEC Committee (06th of August 2025)
MDEC Sub Committee- (25th of July 2025)
94th MDEC Committee (09th of July 2025)
MDEC Sub Committee- (20th of June 2025)
93rd MDEC Committee (04th of June 2025)
92nd MDEC Committee (08th May 2025)
91st MDEC Committee (02nd of April 2025)
90th MDEC Committee (05th March 2025)
89th MDEC Committee (05th of February 2025)
88th MDEC Committee (08th of January 2025)
MDEC Sub Committee (24th of December 2024)
87th MDEC Committee (04th of December 2024)
MDEC Sub Committee (21th of November 2024)
86th MDEC Committee (06th of November 2024)
MDEC Sub Committee (24th of October 2024)
85th MDEC Committee (09th of October 2024)
MDEC Sub Committee (26th of September 2024)
84rd MDEC Committee - ( 04th of September 2024 )
MDEC Sub Committee - ( 22nd August 2024 )
83rd MDEC Committee - ( 07th of August 2024 )
82nd MDEC Committee (17th of July 2024 )
MDEC Sub Committee - ( 26th of June 2024 )
From MDEC - ( 10th of March 2022 to MDEC 5th of June 2022 )
Procedure for submission of Dossier & other applications for Medical device registration
All dossiers and other applications for medical device registration will be accepted after applying by filling out the Google form linked below or scanning the provided QR code.

Fill out the following relevant checklist and submit two copies along with the dossier to the accepting point.
( Listed Devices, class I General Medical Devices and class A In Vitro Diagnostic Devices (Applicable for attached appendix 1))